Skip to main content

Agilent Technologies' OneSeq

Agilent Technologies has launched OneSeq, an all-in-one target enrichment product for next-generation sequencing. OneSeq is designed to detect and analyze copy number variations, loss of heterozygosity, and mutations in a single reaction for use in constitutional disease research. Powered by the company's SureSelect target enrichment platform, OneSeq will help laboratories involved in cytogenetic research save time gathering and analyzing complex, multifactorial data, Agilent said.

Agilent showcased the technology at the Advances in Genome Biology and Technology conference in Marco Island, Fla., this week.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.